Jared Bauer, IONIQ CEO, is now also Chair of BioHive
Salt Lake City, UT, July 19, 2023 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that Mr. Jared Bauer, CEO, has accepted the Chairmanship of BioHive. Mr. Bauer will continue to lead IONIQ Sciences alongside this appointment. BioHive exists to enhance and unite the more than 1,300 companies that comprise Utah’s large, fast growing life science and healthcare innovation ecosystem.
“I vividly recall hosting stakeholders and thought leaders in my backyard in 2020 where we envisioned and founded BioHive,” said Mr. Bauer. “BioHive’s goals of championing our industry through recruitment, fostering diversity, promoting industry accomplishments, and workforce development will continue to make crucial innovations that boost our state’s economy and help patients around the globe. It is a privilege to represent the more than 130,000 Utahns that directly and indirectly comprise BioHive – researchers, developers, and manufacturers of therapeutics, devices, and diagnostics, as well as lab facilities, healthcare delivery systems, digital health, health IT, and the supply-chain businesses that support these industries.”
“On behalf of BioHive and the Board of Directors, I would like to thank Chris Gibson for his leadership and contributions to BioHive,” said Aimee Edwards, Executive Director. “Chris has helped BioHive grow into the robust and collaborative organization it is today. I am thrilled to welcome Jared Bauer as our new Chairman of the Board. Jared brings years of experience in Utah’s life sciences community and will be instrumental in our efforts to continue growing BioHive.”
BioHive’s co-founder, Cindy Dunkle (Chief People Officer, Denali Therapeutics), will assume the role as Co-Chair of the Board. “I am honored and excited to assume the role as BioHive’s Co-Chair,” said Dunkle. “BioHive has grown significantly since Chris and I co-founded it back in 2020. Our dedication to branding, building, and bringing together BioHive over the last few years is remarkable. I am proud of BioHive’s commitment to Utah’s life sciences community, and I am excited to continue supporting our community.”
About IONIQ Sciences, Inc.
IONIQ Sciences, Inc. is developing an advanced multi-cancer screening technology for early detection that has the potential to expand the therapeutic window, dramatically improve survivability and reduce the cost of healthcare. IONIQ Sciences operates at the confluence of its Electrical Impedance Analytics (EIA) or bioimpedance technology and Artificial Intelligence (AI). IONIQ Science’s first product utilizing its proprietary analytic platform, the IONIQ ProLung Test™ for lung cancer, has been designated a Breakthrough Device by the U.S. FDA.
BioHive is a thriving collective of more than 1,300 companies representing the life science and healthcare innovation ecosystem of Utah’s economy. BioHive embraces diversity and promote collaboration. BioHive includes researchers, developers, and manufacturers of therapeutics, devices, and diagnostics, as well as laboratory facilities, healthcare delivery systems, digital health, health IT, and supply-chain businesses that support these industries. BioHive has been the fastest-growing life science community in America since 2012. For more information on BioHive, visit biohive.com.
For further information about IONIQ Sciences, Inc., please contact:
Andy Robertson | 1-801-736-0729 | acr@IONIQsciences.com
IONIQ Sciences, Vice President of Business Development
IONIQ Sciences, Inc.
350 W. 800 N., Suite 214
Salt Lake City, Utah 84103